{
    "id": 26623,
    "fullName": "BIRC3 mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BIRC3 mutant indicates an unspecified mutation in the BIRC3 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 330,
        "geneSymbol": "BIRC3",
        "terms": [
            "BIRC3",
            "AIP1",
            "API2",
            "c-IAP2",
            "CIAP2",
            "HAIP1",
            "HIAP1",
            "IAP-1",
            "MALT2",
            "MIHC",
            "RNF49"
        ]
    },
    "variant": "mutant",
    "createDate": "05/24/2017",
    "updateDate": "08/17/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11010,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, TRC694 inhibited proliferation of multiple myeloma cells harboring BIRC3 mutations in culture (AACR 2017 Annual Meeting, Abstract nr 4199).",
            "molecularProfile": {
                "id": 27882,
                "profileName": "BIRC3 mutant"
            },
            "therapy": {
                "id": 5772,
                "therapyName": "TRC694",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8981,
                    "pubMedId": null,
                    "title": "Inhibition of NF-kB inducing kinase (NIK) selectively abrogates NIK and TRAF3 mutant multiple myeloma tumor growth",
                    "url": "http://www.abstractsonline.com/pp8/#!/4292/presentation/3906"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27882,
            "profileName": "BIRC3 mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}